Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled, phase I study to assess safety, tolerability and
pharmacokinetics of single/multiple ascending doses of atb-346 orally administered in healthy
male and female subjects.